140 results
Page 5 of 7
8-K
EX-5.1
utmi5dhjmeqwu0 st5
7 Sep 18
Adaptimmune Therapeutics plc Announces Closing of Registered Direct Offering of American Depositary Shares
12:00am
8-K
EX-99.1
tbu0n4j6j5kl1tchvpuv
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
S-3ASR
EX-5.1
dmyrifpq3bcd62mn
12 Jul 18
Automatic shelf registration
4:30pm
S-3ASR
xztk95lxa3eed4
12 Jul 18
Automatic shelf registration
4:30pm
8-K
EX-99.1
0roi2
6 Jul 18
Departure of Directors or Certain Officers
5:00pm
8-K
EX-14.1
4lacw
24 Jul 17
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
8-K
EX-5.1
4dr3c f3cglomb3a
10 Apr 17
Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering
12:00am
10-K
uxd5ey
13 Mar 17
Annual report
12:00am
10-K
EX-10.18
vjuh u0svp
13 Mar 17
Annual report
12:00am